Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 312-320, February 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higgins, N. P.
Right arrow Articles by Strauss, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, N. P.
Right arrow Articles by Strauss, B. S.

Differences in the Ability of Human Lymphoblastoid Lines to Exclude Bromodeoxyuridine and in Their Sensitivity to Methyl Methanesulfonate and to Incorporated [3H]Thymidine1

N. Patrick Higgins2 and Bernard S. Strauss3

Department of Microbiology, University of Chicago, Chicago, Illinois 60637

Six Burkitt's lymphoma-derived lines were more resistant to methyl methanesulfonate than were six lymphoblastoid lines derived by in vitro transformation as measured by cloning ability in soft agar. The differences were due to cell response rather than to reactivity. Lymphoblastoid lines were also more sensitive to [3H]thymidine incorporated along with bromodeoxyuridine than were the lymphoma lines tested. All lines showed excision repair activity as measured by the benzoylated napthoylated DEAE cellulose method, although there were quantitative differences in the activity of different lines. Most lymphoblastoid lines synthesize DNA of lower density when incubated in analog-containing medium due to their ability to discriminate against bromodeoxyuridine and to select for thymidine in a mixture. All the lymphoma cell lines tested were unable to discriminate between thymidine and bromodeoxyuridine. The ability of lymphoma cells to produce large quantities of dense radioactive, doubly substituted DNA when incubated in medium with bromodeoxyuridine and thymidine is due to their inability to discriminate between nucleosides and to their resistance to incorporated [3H]thymidine.

1 Supported by NIH Grants CA 14599 and Al-12116 and Department of Energy Grant EY76-S-02-2040.

2 Trainee of a genetics training program funded by the NIH (GM 00090). Present address: Department of Biochemistry, The University of Wyoming, Laramie, Wyoming 82071.

3 To whom requests for reprints should be addressed, at Department of Microbiology, The University of Chicago, 920 East 58th Street, Chicago, Ill. 60637.

Received 11/14/77. Accepted 10/23/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.